Aromics

Developing novel RNA-targeting anticancer agents

OWNER

Carme Plasencia (See Profile)


Sector

Cancer therapeutics

Stage

Development, market readiness, clinical trial

Country

España


patented technology, first-in-class RNA anticancre agent, pre-IND compeleted

Expected Phase 1/2 clinical trials

Innovative mechanism of action, hard-to-treat tumors

Status

Approved

IP Type

Patent

Time

8 years

Countries

France
Germany
Italy
Japan
Spain
USA
United Kingdom

Coverage

Protects family of anticancer agents

Know more of this patent

View more

Status

Pending

IP Type

Patent

Time

–

Countries

Spain

Coverage

Manufacture procedure still on revision

Know more of this patent

View more

Status

–

IP Type

Trade secret

Time

–

Countries

Coverage

Molecular data and Preclinical development of compounds

This information is confidential, do not share or copy.

You can visit their website or

Download the Pitch Deck

Under evaluation at least till: 30th of May 2023

If you want to have more information or you want to review the project, you have to login or register

KEEP REVIEWING

©2023 BioExpert Network

About cookies

This website uses cookies to give you the best user experience. If you continue browsing you are giving your consent for the acceptance of those cookies and the acceptance of our cookies policy.

If you continue to browse and use this website you are agreeing to comply with and be bound by the following Terms of Use

ACEPTAR
Aviso de cookies

Log in with your credentials

or    

Forgot your details?

Create Account

Skip to toolbar